Advertisement
Canada markets open in 4 hours 7 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7311
    -0.0009 (-0.13%)
     
  • CRUDE OIL

    83.05
    -0.31 (-0.37%)
     
  • Bitcoin CAD

    90,920.23
    +268.53 (+0.30%)
     
  • CMC Crypto 200

    1,431.98
    +7.88 (+0.55%)
     
  • GOLD FUTURES

    2,331.30
    -10.80 (-0.46%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,699.00
    +92.25 (+0.52%)
     
  • VOLATILITY

    15.82
    +0.13 (+0.83%)
     
  • FTSE

    8,080.07
    +35.26 (+0.44%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Where Will AbbVie Be in 3 Years?

Where Will AbbVie Be in 3 Years?

In spite of market turmoil, this year has been bright so far for AbbVie (NYSE: ABBV). The company's star drug Humira continues to grow, and even reached the milestone of more than $20 billion in sales last year. Its other immunology drugs and the neuroscience business also are thriving.